Hossam M.M. Arafa

1.1k total citations
28 papers, 910 citations indexed

About

Hossam M.M. Arafa is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Hossam M.M. Arafa has authored 28 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 5 papers in Obstetrics and Gynecology. Recurrent topics in Hossam M.M. Arafa's work include Chemotherapy-induced organ toxicity mitigation (6 papers), Uterine Myomas and Treatments (5 papers) and Metabolism and Genetic Disorders (3 papers). Hossam M.M. Arafa is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (6 papers), Uterine Myomas and Treatments (5 papers) and Metabolism and Genetic Disorders (3 papers). Hossam M.M. Arafa collaborates with scholars based in Egypt, United States and Indonesia. Hossam M.M. Arafa's co-authors include Farid M.A. Hamada, Ramadan A.M. Hemeida, Ali H. El‐Bahrawy, Ayman Al‐Hendy, Memy H. Hassan, Samar F. Darwish, Ashraf B. Abdel‐Naim, Wesam M. El‐Bakly, Ebtehal El‐Demerdash and Mariane G. Tadros and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and American Journal of Obstetrics and Gynecology.

In The Last Decade

Hossam M.M. Arafa

28 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hossam M.M. Arafa Egypt 19 257 105 102 99 95 28 910
Sherine M. Rizk Egypt 20 399 1.6× 52 0.5× 81 0.8× 70 0.7× 33 0.3× 42 1.0k
Mohammad Hassan Khadem Ansari Iran 21 337 1.3× 21 0.2× 113 1.1× 54 0.5× 49 0.5× 99 1.2k
Anita Roy India 18 356 1.4× 31 0.3× 160 1.6× 36 0.4× 49 0.5× 46 960
Yüksel Aliyazıcıoğlu Türkiye 22 440 1.7× 22 0.2× 126 1.2× 76 0.8× 25 0.3× 99 1.4k
Anna Bogacz Poland 15 296 1.2× 72 0.7× 57 0.6× 108 1.1× 11 0.1× 102 919
Jamshid Karimi Iran 24 480 1.9× 23 0.2× 288 2.8× 114 1.2× 36 0.4× 82 1.5k
B. Mizrak Türkiye 12 131 0.5× 16 0.2× 108 1.1× 38 0.4× 21 0.2× 20 634
Dimiter Avtanski United States 17 453 1.8× 14 0.1× 99 1.0× 32 0.3× 60 0.6× 51 1.1k
Wei Peng China 21 665 2.6× 171 1.6× 11 0.1× 84 0.8× 20 0.2× 61 1.3k
Vladimír Semecký Czechia 16 167 0.6× 90 0.9× 50 0.5× 34 0.3× 8 0.1× 39 790

Countries citing papers authored by Hossam M.M. Arafa

Since Specialization
Citations

This map shows the geographic impact of Hossam M.M. Arafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hossam M.M. Arafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hossam M.M. Arafa more than expected).

Fields of papers citing papers by Hossam M.M. Arafa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hossam M.M. Arafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hossam M.M. Arafa. The network helps show where Hossam M.M. Arafa may publish in the future.

Co-authorship network of co-authors of Hossam M.M. Arafa

This figure shows the co-authorship network connecting the top 25 collaborators of Hossam M.M. Arafa. A scholar is included among the top collaborators of Hossam M.M. Arafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hossam M.M. Arafa. Hossam M.M. Arafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdelhakim, Heba K., et al.. (2021). An in vitro cytotoxicity of glufosfamide in HepG2 cells relative to its nonconjugated counterpart. Journal of the Egyptian National Cancer Institute. 33(1). 22–22. 2 indexed citations
4.
Arafa, Hossam M.M., et al.. (2014). Carnitine Deficiency: A Causative Clue or a Sequel in Carboplatin Myelosuppression. 3(4). 1 indexed citations
5.
Hassan, Memy H., Salama A. Salama, Dong Zhang, et al.. (2009). Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model. Fertility and Sterility. 93(1). 239–250. 31 indexed citations
6.
Arafa, Hossam M.M.. (2009). Uroprotective Effects of Curcumin in Cyclophosphamide‐Induced Haemorrhagic Cystitis Paradigm. Basic & Clinical Pharmacology & Toxicology. 104(5). 393–399. 34 indexed citations
7.
Hassan, Memy H., Dong Zhang, Farid M.A. Hamada, et al.. (2009). Towards Fibroid Gene Therapy: Adenovirus-Mediated Delivery of Herpes Simplex Virus 1 Thymidine Kinase Gene/Ganciclovir Shrinks Uterine Leiomyoma in the Eker Rat Model. Gynecologic and Obstetric Investigation. 68(1). 19–32. 21 indexed citations
8.
Arafa, Hossam M.M., et al.. (2009). Acetyl-l-Carnitine Ameliorates Caerulein-induced Acute Pancreatitis in Rats. Basic & Clinical Pharmacology & Toxicology. 105(1). 30–36. 23 indexed citations
9.
Arafa, Hossam M.M.. (2009). Possible contribution of β-glucosidase and caspases in the cytotoxicity of glufosfamide in colon cancer cells. European Journal of Pharmacology. 616(1-3). 58–63. 27 indexed citations
10.
Hassan, Memy H., Eduardo Eyzaguirre, Hossam M.M. Arafa, et al.. (2008). Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice. American Journal of Obstetrics and Gynecology. 199(2). 156.e1–156.e8. 37 indexed citations
12.
Arafa, Hossam M.M.. (2008). Carnitine deficiency: a possible risk factor in paracetamol hepatotoxicity. Archives of Toxicology. 83(2). 139–150. 18 indexed citations
13.
Hassan, Memy H., et al.. (2008). Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cells. Human Reproduction. 23(3). 514–524. 15 indexed citations
14.
Arafa, Hossam M.M., et al.. (2007). Anti-fibrotic effect of meloxicam in a murine lung fibrosis model. European Journal of Pharmacology. 564(1-3). 181–189. 46 indexed citations
15.
Hassan, Memy H., Salama A. Salama, Hossam M.M. Arafa, Farid M.A. Hamada, & Ayman Al‐Hendy. (2007). Adenovirus-Mediated Delivery of a Dominant-Negative Estrogen Receptor Gene in Uterine Leiomyoma Cells Abrogates Estrogen- and Progesterone-Regulated Gene Expression. The Journal of Clinical Endocrinology & Metabolism. 92(10). 3949–3957. 28 indexed citations
17.
Tadros, Mariane G., Amani E. Khalifa, Ashraf B. Abdel‐Naim, & Hossam M.M. Arafa. (2005). Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype. Pharmacology Biochemistry and Behavior. 82(3). 574–582. 66 indexed citations
18.
Arafa, Hossam M.M., et al.. (2005). Abatement by naringenin of doxorubicin-induced cardiac toxicity in rats.. PubMed. 17(4). 291–300. 40 indexed citations
19.
Arafa, Hossam M.M., et al.. (2003). Immunomodulatory effects of l-carnitine and q10 in mouse spleen exposed to low-frequency high-intensity magnetic field. Toxicology. 187(2-3). 171–181. 28 indexed citations
20.
ABDEL-WAHAB, MOHAMED H., et al.. (2002). POTENTIAL PROTECTIVE EFFECT OF MELATONIN AGAINST DIBROMOACETONITRILE-INDUCED OXIDATIVE STRESS IN MOUSE STOMACH. Pharmacological Research. 46(3). 287–293. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026